Danisco A/S
VC Fund
Copenhagen, Denmark
Danisco A/S is a VC fund in Copenhagen focused on Biotechnology and Industrial. Danisco A/S produces and sells food ingredients and industrial bioproducts primarily in Europe, North America, Latin America, and the Asia Pacific. The company's Emulsifiers division supplies food emulsifiers; and GRINDSTED SOFT-N-SAFE, a vegetable-based plasticizer for the plastic industry. Its Gums and Systems division offerstextural ingredients based on a portfolio of hydrocolloids and functional systems. It produces six types of hydrocolloids that are manufactured from selected natural raw materials, such as seaweed, citrus fruits, locust bean, and guar seeds. This division serves the food, cosmetics, paper, textiles, and pharmaceuticals industries. The company's Sweeteners division supplies specialty sweeteners and related ingredients for use in food, pharmaceuticals, sports nutrition, and oral hygiene products. It offers sweeteners, including xylitol, fructose, and Litesse polydextrose that are used to reduce the risk of lifestyle diseases, such as obesity, diabetes, and tooth decay. Its Cultures division produces cultures and media to the dairy, meat, and health industries. It offers probiotic cultures to stimulate gut health and enhance the immune system in food, dietary supplements, and beverages. This division also supplies natural food protection solutions, such as antioxidants and antimicrobials; and enzymes for cheese production. The company's Genencor division discovers, develops, and manufactures enzymes and bio-based solutions for the animal nutrition, biodefense, biosafety, carbohydrate processing, food and beverages, fuel ethanol, laundry detergents, and textile industries. It produces second generation bioethanol from non-food raw materials. Danisco was founded in 1989 and is headquartered in Copenhagen K, Denmark.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Danisco A/S invests in
Stages Danisco A/S invests in
Countries Danisco A/S invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Søren Bjerre-Nielsen
|
|||
|
Tom Knutzen
|
|||
Investment Focus
Industry
- Biotechnology 2 (100%)
- Industrial 1 (50%)
- Health Care 1 (50%)
- Biomass Energy 1 (50%)
- Food and Beverage 1 (50%)
Stage
- Series A 1 (50%)
- Series C 1 (50%)
Country
- Germany 1 (50%)
- United States 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Søren Bjerre-Nielsen
CFO
|
CFO | Total investments: 0 | Find email | |
|
Tom Knutzen
CEO
|
CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
DIREVO Industrial Biotechnology
|
DIREVO provides customized solutions for various industries via the development and optimization of biocatalysts with its proprietary ultra-high-throughput screening platform. Serving the Feed & Food industries and chemical / biorefinery businesses, DIREVO products are developed either independently or in conjunction with global leaderssuch as Genencor (a division of Danisco A/S), AB Enzymes, Roal Ltd. and Nestlé. DIREVO Industrial Biotechnology GmbH is privately owned and located in Cologne, Germany. The shareholders include Wölbern EquityPartner GmbH (Hamburg), NRW Bank (Düsseldorf), TVM Capital (Munich), Danisco A/S (Copenhagen), a private equity firm affiliated with Sparkasse KölnBonn (Cologne), SandersMorrisHarris EnzymesLLC (New York), Mulligan BioCapital (Hamburg), and several private investors. | $16.8M / Series C / Oct 18, 2007 | |
Redpoint Bio
|
Redpoint Bio is following a strategy focused on preserving the value of the License and Commercialization Agreement it entered into with International Flavors and Fragrances, Inc. (IFF), a global leader in the food and beverage industry. As part of this strategy, the Company continues its efforts to reduce its liabilities and sell its remainingassets. Given its lack of resources, the Company is not currently performing any research and development activities. | $10.2M / Series A / Nov 13, 2003 |
Co-Investors
Aperture Venture Partners
1 deal together
Bankhaus Wölbern
1 deal together
Cargill Ventures
1 deal together
DuPont Ventures
1 deal together
Mulligan BioCapital
1 deal together
NJTC Venture Fund
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Danisco A/S invest in?
Danisco A/S invests primarily in Biotechnology, Industrial and Health Care startups, most often at Series A and Series C stage. Most of the 2 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Danisco A/S?
Public channels for Danisco A/S include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Danisco A/S?
The team at Danisco A/S includes Søren Bjerre-Nielsen (CFO) and Tom Knutzen (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
